Novavax apresenta 90% de eficácia geral e 100% de proteção contra casos moderados e graves da COVID-19 no estudo de Fase 3 PREVENT-19 ...Middle East

93% de eficácia contra as variantes de preocupação e de interesse predominantes 91% de eficácia em populações de alto risco 100% de eficácia contra as variantes "não consideradas de preocupação/interesse" Todas as hospitalizações/mortes pela COVID-19 ocorreram no grupo placebo Empresa...

Hence then, the article about novavax apresenta 90 de eficacia geral e 100 de protecao contra casos moderados e graves da covid 19 no estudo de fase 3 prevent 19 was published today ( Tuesday 15/06/2021 - 04:30 AM ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Novavax apresenta 90% de eficácia geral e 100% de proteção contra casos moderados e graves da COVID-19 no estudo de Fase 3 PREVENT-19 )

Also on site :

• French court denies extradition of ex-Tunisian President Ben Ali’s daughter
• Ford and Toyota issue major South African car recall
• ‘It all depends on the crop’: Gulf crisis hits South Asia farmers